Interferon-γ-treated renal tubular epithelial cells induce allospecific tolerance

Kidney International

Volumn 53, Issue 3, 1998, Pages 679-689

  Frasca, Loredana ^b   Marelli Berg, Federica ^b   Imami, Nesrina ^b   Potolicchio, Ilaria ^b   Carmichael, Paul ^b   Lombardi, Giovanna ^b   Lechler, Robert ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

Allospecific tolerance; Epithelial cells; Graft survival; Interferon ; Transplantation

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CYTOKINE; HLA B7 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; KIDNEY TUBULE EPITHELIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031953109     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00800.x     Document Type: Article

References (30)

1. LAFFERTY KJ, COOLEY MA, WOOLNOUGH J, WALKER KZ: Thyroid allograft immunogenicity is reduced after a period in organ culture. Science 188:259-261, 1975
2. LAFFERTY KJ, BOOTES A, DART G, TALMAGE DW: Effect of organ culture on the survival of thyroid allografts in mice. Transplantation 22:138-149, 1976
3. LACEY PE, DAVIE JM, FINKE EH: Prolongation of islet xenograft survival without continuous immunosuppression. Science 209:283-285, 1980
4. BATCHELOR JR, WELSH KI, MAYNARD A, BURGOS H: Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med 150:455-464, 1979
5. LECHLER RI, BATCHELOR JR: Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 155:31-41, 1982
6. LECHLER RI, BATCHELOR JR: Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J Exp Med 156:1835-1841, 1982
7. HALL B, JELBART K, GURLEYAND K, DORSCH SE: Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells. J Exp Med 162:1683-1694, 1985
8. DEACOCK S, LECHLER RI: Positive correlation of T cell sensitisation with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation (Baltimore) 54:338-343, 1992
9. MASON PD, ROBINSON SM, LECHLER RI: Detection of donor-specific hyporesponsiveness following late failure of human renal allograft. Kidney Int 50:1019-1025, 1996
10. BRAUN MY, MCCORMACK A, WEBB G, BATCHELOR JR: Evidence for clonal anergy as a mechanism responsible for the maintenance of transplantation tolerance. Eur J Immunol 23:1462-1468, 1993
11. FERNAND JP, CHEVALIER A, BROUET JC: Characterization of a monoclonal antibody recognizing a monomorphic determinant of the alpha chain of class II DQ antigens. Scand J Immunol 24:313-319, 1986
12. SMITH SH, BROWN MH, ROWE D, CALLARD RE, BEVERLEY PLC: Functional subset of human helper-inducer cells defined by a new monoclonal antibody, UCHL 1. Immunology 58:63-69, 1986
13. MUNRO CS, CAMPBELL DA, DUBOIS RM, MITCHELL DN, COLE PJ, POULTER LW: Suppression associated lymphocyte markers in lesions of sarcoidosis. Thorax 43:471-477, 1988
14. LANE P, GERHARD W, HUBELE S, LANZAVECCHIA A, MCONNEL F: Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human γ1. J Immunol 80:56-61, 1993
15. HU-LI J, OHARA J, WATSON C, TSANG W, PAUL, WE: Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutants of that line (CT.4S). J Immunol 142: 800-807, 1989
16. SIDHU S, DEACOCK S, BAL V, BATCHELOR JR, LOMBARDI G, LECHLER RI: Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactivc responder cells. J Exp Med 176:875-880, 1992
17. TAN P, ANASETTI C, HANSEN JA, MELROSE J, BRUNVAND M, BRADSHAW J, LEDBETTER JA, LINSLEY PS: Induciton of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 177:165-173, 1993
18. BOUSSIOTIS VA, FREEMAN GJ, GRAY G, GRIBBEN JG, NADLER LM: B7 but not intracellular adhesion molecule-1 prevents the induction of human alloantigen-specific tolerance. J Exp Med 178:1753-1763, 1993
19. MARELLI-BERG FM, HARGREAVES REG, CARMICHAEL P, DORLING A, LOMBARDI G, LECHLER RI: Major Histocompatibility Complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med 183:1603-1612, 1996
20. QUILL H, SCHWARTZ RH: Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative non-responsiveness. J Immunol 138:3704-3712, 1987
21. JENKINS MK, SCHWARTZ RH: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165:302-319, 1987
22. KIRBY JA, IKUTA S, CLARK K, PROUD G, LENNARD TW, TAYLOR RM: Renal allograft rejection: Investigation of alloantigen presentation by cultured human renal epithelial cells. Immunology 72:411-417, 1991
23. WILSON JL, PROUD G, FORSYTHE JL, TAYLOR RM, KIRBY JA: Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody. Transplantation 59:91-97, 1991
24. SINGER GG, YOKOYAMA H, BLOOM RD, JENNIKAR AM, NABAVI N, KELEY VR: Stimulated renal tubular epithelial cells induce anergy in CD4+ T cells. Kidney Int 44:1030-1035, 1993
25. VISSCHER D, CAREY J, HO H, TURZA N, KUPIN W, VENKAT KK, ZARBO R: Histologic and immunophenotypic evaluation of pretreatment renal biopsies on OKT3-treated allograft rejections. Transplantation (Baltimore) 51:1023-1028, 1991
26. STARZL TE, DEMETRIS AJ, MURASE N, THOMSON AW, TRUCCO M, RICORDI C: Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation. Immunol Today 14:326-332, 1993
27. DEMETRIS AJ, MURASE N, DELANEY DP, WOAN M, FUNG JJ, STARZL TE: The liver allograft, chronic (ductopenic) rejection, and microchimerism: What can they teach us? Transplant Proc 27:67-70, 1995
28. BENICHOU G, TAKIZAWA PA, OLSON CA, MCMILLAN M, SERCARZ EE: Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during rejection. J Exp Med 175:305-308, 1992
29. FANGMANN J, DALCHAU R, FABRE JW: Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J Exp Med 175:1521-1529, 1992
30. LIU Z, SUN YK, XI YP, MAFFEI A, REED E, HARRIS P, SUCIU FOCA N: Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 177:1643-1650, 1993-